Literature DB >> 23899992

Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.

Mascha S Recks1, Eva R Stormanns, Jonas Bader, Stefan Arnhold, Klaus Addicks, Stefanie Kuerten.   

Abstract

Studies of MS histopathology are largely dependent on suitable animal models. While light microscopic analysis gives an overview of tissue pathology, it falls short in evaluating detailed changes in nerve fiber morphology. The ultrastructural data presented here and obtained from studies of myelin oligodendrocyte glycoprotein (MOG):35-55-induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice delineate that axonal damage and myelin pathology follow different kinetics in the disease course. While myelin pathology accumulated with disease progression, axonal damage coincided with the initial clinical disease symptoms and remained stable over time. This pattern applied both to irreversible axolysis and early axonal pathology. Notably, these histopathological patterns were reflected by the normal-appearing white matter (NAWM), suggesting that the NAWM is also in an active neurodegenerative state. The data underline the need for neuroprotection in MS and suggest the MOG model as a highly valuable tool for the assessment of different therapeutic strategies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4% paraformaldehyde/4% glutaraldehyde; Axonal pathology;; B6; C57BL/6; CFA; CNS; CST; DC; EAE; EAE;; Electron microscopy;; FGF; IFA; MBP; MBP-PLP fusion protein; MOG; MOG:35–55;; MP4; MS; NAWM; NNND; Neurodegeneration;; OPC; PFA-GA; PLP; VLC; central nervous system; complete Freund's adjuvant; corticospinal tract; dorsal column; experimental autoimmune encephalomyelitis; fibroblast growth factor; incomplete Freund's adjuvant; multiple sclerosis; myelin basic protein; myelin oligodendrocyte glycoprotein; nearest neighbor neurofilament distance; normal-appearing white matter; oligodendrocyte precursor cells; proteolipid protein; ventrolateral column

Mesh:

Substances:

Year:  2013        PMID: 23899992     DOI: 10.1016/j.clim.2013.06.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

1.  Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin.

Authors:  Antoine Philippe Fournier; Aurélien Quenault; Sara Martinez de Lizarrondo; Maxime Gauberti; Gilles Defer; Denis Vivien; Fabian Docagne; Richard Macrez
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

2.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

3.  Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.

Authors:  Andrea Schampel; Oleg Volovitch; Tobias Koeniger; Claus-Jürgen Scholz; Stefanie Jörg; Ralf A Linker; Erhard Wischmeyer; Marie Wunsch; Johannes W Hell; Süleyman Ergün; Stefanie Kuerten
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-05       Impact factor: 11.205

Review 4.  Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).

Authors:  Rachel E Klaren; Robert W Motl; Jeffrey A Woods; Stephen D Miller
Journal:  J Neuroimmunol       Date:  2014-06-24       Impact factor: 3.478

Review 5.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

Review 6.  Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.

Authors:  Andrea Rottlaender; Stefanie Kuerten
Journal:  Int J Mol Sci       Date:  2015-07-01       Impact factor: 5.923

7.  Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.

Authors:  Jeffery D Haines; Olivier Herbin; Belén de la Hera; Oscar G Vidaurre; Gregory A Moy; Qingxiang Sun; Ho Yee Joyce Fung; Stefanie Albrecht; Konstantina Alexandropoulos; Dilara McCauley; Yuh Min Chook; Tanja Kuhlmann; Grahame J Kidd; Sharon Shacham; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2015-02-23       Impact factor: 24.884

8.  Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.

Authors:  Johanna Prinz; Aylin Karacivi; Eva R Stormanns; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

9.  Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis.

Authors:  Camille A Juźwik; Sienna Drake; Marc-André Lécuyer; Radia Marie Johnson; Barbara Morquette; Yang Zhang; Marc Charabati; Selena M Sagan; Amit Bar-Or; Alexandre Prat; Alyson E Fournier
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

10.  Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.

Authors:  Jayshree Samanta; Ethan M Grund; Hernandez M Silva; Juan J Lafaille; Gord Fishell; James L Salzer
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.